PHARMACY AND P
Department
Universidade de Santiago de Compostela
Santiago de Compostela, EspañaPublications in collaboration with researchers from Universidade de Santiago de Compostela (11)
2024
-
Bioequivalence risk assessment of oral formulations containing racemic ibuprofen through a chiral physiologically based pharmacokinetic model of ibuprofen enantiomers
European Journal of Pharmaceutics and Biopharmaceutics, Vol. 199
-
Towards precision medicine of long-acting aripiprazole through population pharmacokinetic modelling
Psychiatry Research, Vol. 333
2023
2022
-
A Review of Population Pharmacokinetic Analyses of Linezolid
Clinical Pharmacokinetics, Vol. 61, Núm. 6, pp. 789-817
2021
-
Review of pharmacokinetics and pharmacogenetics in atypical long-acting injectable antipsychotics
Pharmaceutics, Vol. 13, Núm. 7
2019
-
Pharmacokinetics of intravitreal anti-VEGF drugs in age-related macular degeneration
Pharmaceutics, Vol. 11, Núm. 8
2017
2016
-
Intestinal Permeability of β-Lapachone and Its Cyclodextrin Complexes and Physical Mixtures
European Journal of Drug Metabolism and Pharmacokinetics, Vol. 41, Núm. 6, pp. 795-806
2015
-
Higher physiopathogenicity by Fasciola gigantica than by the genetically close F. hepatica: Experimental long-term follow-up of biochemical markers
Transactions of the Royal Society of Tropical Medicine and Hygiene, Vol. 110, Núm. 1, pp. 55-66
2009
-
MM3-ELISA detection of Fasciola hepatica coproantigens in preserved human stool samples
American Journal of Tropical Medicine and Hygiene, Vol. 81, Núm. 1, pp. 156-162
-
MM3-ELISA evaluation of coproantigen release and serum antibody production in sheep experimentally infected with Fasciola hepatica and F. gigantica
Veterinary Parasitology, Vol. 159, Núm. 1, pp. 77-81